JERW, JO3109311019

Jerash Holdings stock (JO3109311019): Q4 earnings and FY outlook in focus

Veröffentlicht: 12.05.2026 um 17:26 Uhr, Redaktion AD HOC NEWS, Redaktionelle Verantwortung: Rafael Müller (Chefredaktion)

Jerash Holdings reported Q4 and full-year fiscal 2026 results, providing initial fiscal 2027 guidance amid apparel sector dynamics.

JERW, JO3109311019, Illustration mit AI erstellt.
JERW, JO3109311019, Illustration mit AI erstellt.

Jerash Holdings (NASDAQ:JERW), a manufacturer of apparel for major brands, released its fourth quarter and full-year fiscal 2026 results on May 12, 2026. The company, which produces activewear and woven garments primarily in Jordan, highlighted key financial metrics and issued initial outlook for fiscal 2027, according to company IR as of 05/12/2026.

The stock traded at $4.76, down 1.12 or 19.03% as of 11:18 AM Eastern on NYSE, per MarketBeat as of 05/12/2026. This movement follows the earnings release, reflecting investor reactions to the results and guidance.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: Jerash Holdings (US) Inc.
  • Sector/industry: Apparel manufacturing
  • Headquarters/country: Jordan/United States
  • Core markets: US retailers and brands
  • Key revenue drivers: Activewear and woven garments
  • Home exchange/listing venue: Nasdaq (JERW)
  • Trading currency: USD

Official source

For first-hand information on Jerash Holdings, visit the company’s official website.

Go to the official website

Jerash Holdings: core business model

Jerash Holdings operates cut-and-sew manufacturing facilities in Jordan, focusing on private label sportswear and woven products for US-based mass market retailers. The company sources fabric from Asia and exports finished goods primarily to the United States, benefiting from duty-free access under trade agreements. This model positions Jerash as a cost-efficient supplier in the competitive apparel sector.

With factories in Jordan, Jerash emphasizes vertical integration in sewing and finishing processes. It serves major clients including Under Armour, as referenced in recent market data. The business relies on long-term contracts and purchase orders from branded athletic and lifestyle apparel providers.

Main revenue and product drivers for Jerash Holdings

Revenue stems from knit and woven activewear, including fleece, sports outerwear, pants, shirts and jackets. For fiscal 2026, the company reported results reflecting demand from US retailers amid shifting consumer spending patterns, per IR release as of 05/12/2026. Key drivers include volume growth in core categories and operational efficiencies.

Jerash's exposure to the US market makes it sensitive to retail inventories and promotional activity. The initial fiscal 2027 outlook signals management's view on order backlogs and capacity utilization.

Industry trends and competitive position

The global apparel manufacturing industry faces nearshoring trends, supply chain diversification and sustainability pressures. Jerash benefits from its Middle East location, offering lower labor costs than many Asian peers while providing quicker turnaround to US ports compared to farther suppliers.

Competitors include Delta Apparel and Gildan Activewear. Jerash's niche in branded private label positions it well for US investors tracking small-cap industrials with emerging market exposure but strong Western customer ties.

Why Jerash Holdings matters for US investors

Listed on Nasdaq, Jerash provides US investors access to apparel outsourcing with direct ties to American brands like Under Armour. Its Jordan-based operations offer geopolitical stability relative to some Asian hubs, plus favorable trade terms into the US market, enhancing relevance amid tariff discussions.

Conclusion

Jerash Holdings' fiscal 2026 results and fiscal 2027 outlook underscore its role in the US apparel supply chain. The recent share price reaction highlights market sensitivity to earnings delivery. Investors monitor upcoming order flows and retail sector health for further developments.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | JO3109311019 | JERW | boerse | 69315383 |